ClinConnect ClinConnect Logo
Search / Trial NCT05148052

Effect of Upper Extremity Rehabilitation Using Immersive Virtual Reality in Chronic Stroke Patients.

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Nov 23, 2021

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Stroke Virtual Reality Upper Extremity Paresis

ClinConnect Summary

This clinical trial is studying how virtual reality exercises can help improve the movement and function of the arms in people who have had a stroke. The researchers are specifically looking at patients who have been living with the effects of a stroke for at least six months and have some ability to move their arms, but may still struggle with everyday tasks. The goal is to see if using fun, interactive games in a virtual reality setting can support their recovery and make therapy more engaging.

To be eligible for this study, participants should be adults who have had a stroke that affects their upper body movement, but they need to be able to move their arms against gravity. People who have serious cognitive issues, other medical conditions affecting their arms, or a history of certain health problems may not be able to join. Those who do participate can expect to take part in virtual reality sessions designed to help strengthen their arm muscles and improve their daily activities. The study is currently looking for participants, so if you or someone you know fits the criteria, it could be a great opportunity to gain new therapeutic support.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Chronic stroke patients who have passed 6 months or more without additional stroke after the first stroke
  • Patients with upper extremity dysfunction due to stroke (ischemic, hemorrhagic)
  • Patients who can move the upper extremity against gravity with a manual muscle test of grade 3 or higher in the affected shoulder and elbow, respectively
  • Patients who can stably maintain a sitting position
  • Patients who voluntarily agreed to participate in the study
  • Exclusion Criteria:
  • Patients with moderate or severe cognitive impairment with a score of 18 or less on the Mini-Mental Status Examination (K-MMSE)
  • Patients with other causes of upper extremity dysfunction, such as peripheral nerve damage, joint disease, etc.
  • Patients with a history of severe vertigo or epilepsy
  • Patients with medical reasons such as medical conditions that make it difficult to participate in research
  • Patients who may be pregnant or who are pregnant or lactating

About Seoul National University Hospital

Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.

Locations

Seoul, , Korea, Republic Of

Seoul, , Korea, Republic Of

Seoul, , Korea, Republic Of

Seoul, , Korea, Republic Of

Incheon, , Korea, Republic Of

Seoul, , Korea, Republic Of

Yangpyeong, Gyeonggi Do, Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Han Gil Seo, MD, PhD

Principal Investigator

Seoul National University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials